Patents by Inventor Jing-Ya Ding

Jing-Ya Ding has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ANTIBODIES TO GRANULOCYTE-MACROPHAGE COLONY STIMULATING FACTOR AND USES THEREOF
    Publication number: 20210309732
    Abstract: Disclosed herein are anti-GM-CSF antibodies capable of binding to human GM-CSF and blocking its biological activities. Also provided herein are pharmaceutical compositions comprising the anti-GM-CSF antibodies and therapeutic and diagnostic uses of such antibodies.
    Type: Application
    Filed: March 10, 2021
    Publication date: October 7, 2021
    Applicant: ELIXIRON IMMUNOTHERAPEUTICS (HONG KONG) LIMITED
    Inventors: Cheng-Lun KU, Yu-Fang LO, Han-Po SHIH, Jing-Ya DING, Pei-Han CHUNG, Yin-Ping WANG
  • ANTI-INTERFERON GAMMA ANTIBODIES AND USES THEREOF
    Publication number: 20210171624
    Abstract: Provided is an anti-INF-? antibody. Also provided are a composition comprising the antibody and a pharmaceutical application of the antibody in treating IFN-? mediated syndrome.
    Type: Application
    Filed: February 12, 2021
    Publication date: June 10, 2021
    Inventors: Cheng-Lun KU, Han-Po SHIH, Chia-Hao LIN, Jing-Ya DING, Jing-Yi HUANG, Yi-Ting KUO
  • ANTI-INTERFERON GAMMA ANTIBODIES AND USES THEREOF
    Publication number: 20210171625
    Abstract: Provided is an anti-INF-? antibody. Also provided are a composition comprising the antibody and a pharmaceutical application of the antibody in treating IFN-? mediated syndrome.
    Type: Application
    Filed: February 12, 2021
    Publication date: June 10, 2021
    Inventors: Cheng-Lun KU, Han-Po SHIH, Chia-Hao LIN, Jing-Ya DING, Jing-Yi HUANG, Yi-Ting KUO
  • Anti-interferon gamma antibodies and uses thereof
    Patent number: 10968274
    Abstract: Provided is an anti-INF-? antibody. Also provided are a composition comprising the antibody and a pharmaceutical application of the antibody in treating IFN-? mediated syndrome.
    Type: Grant
    Filed: May 7, 2018
    Date of Patent: April 6, 2021
    Assignee: Elixiron Immunotherapeutics (Hong Kong) Limited
    Inventors: Cheng-Lun Ku, Han-Po Shih, Chia-Hao Lin, Jing-Ya Ding, Jing-Yi Huang, Yi-Ting Kuo
  • ANTI-INTERFERON GAMMA ANTIBODIES AND USES THEREOF
    Publication number: 20210054066
    Abstract: Provided is an anti-INF-? antibody. Also provided are a composition comprising the antibody and a pharmaceutical application of the antibody in treating IFN-? mediated syndrome.
    Type: Application
    Filed: May 7, 2018
    Publication date: February 25, 2021
    Inventors: Cheng-Lun KU, Han-Po SHIH, Chia-Hao LIN, Jing-Ya DING, Jing-Yi HUANG, Yi-Ting KUO
  • Epitope recognized by anti-interferon gamma autoantibodies in patients with disseminated mycobacterial infections and the application therefor
    Patent number: 10273278
    Abstract: The present invention discloses a fragment of peptide which can be utilized in patients suffering from a disseminated mycobacterial infection. The fragment of peptide contains a sequence of amino acids with seven residues as formula (I) shown below, wherein X1 is Leucine (Leu); X2 is Proline (Pro); X3 is Glutamate (Glu); X4 is serine (Ser); X5 is Serine (Ser); X6 is Leucine (Leu) and X7 is Arginine (Arg): X1-X2-X3-X4-X5-X6-X7 (I).
    Type: Grant
    Filed: June 17, 2016
    Date of Patent: April 30, 2019
    Assignee: CHANG GUNG UNIVERSITY
    Inventors: Cheng-Lun Ku, Chia-Hao Lin, Chih-Yu Chi, Han-Po Shih, Jing-Ya Ding
  • EPITOPE RECOGNIZED BY ANTI-INTERFERON GAMMA AUTOANTIBODIES IN PATIENTS WITH DISSEMINATED MYCOBACTERIAL INFECTIONS AND THE APPLICATION THEREFOR
    Publication number: 20170114112
    Abstract: The present invention discloses a fragment of peptide which can be utilized in patients suffering from a disseminated mycobacterial infection.
    Type: Application
    Filed: June 17, 2016
    Publication date: April 27, 2017
    Inventors: Cheng-Lun Ku, Chia-Hao Lin, Chih-Yu Chi, Han-Po Shih, Jing-Ya Ding